Provided by Tiger Fintech (Singapore) Pte. Ltd.

Allarity Therapeutics Inc

1.88
-0.0900-4.57%
Post-market: 1.880.00000.00%19:54 EDT
Volume:1.77M
Turnover:3.44M
Market Cap:27.48M
PE:-0.62
High:2.06
Open:1.94
Low:1.87
Close:1.97
52wk High:5.20
52wk Low:0.6138
Shares:14.62M
Float Shares:14.62M
Volume Ratio:0.67
T/O Rate:12.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.0248
EPS(LYR):-15.6529
ROE:-150.58%
ROA:-41.03%
PB:2.26
PE(LYR):-0.12

Loading ...

Sector Update: Health Care Stocks Rise Tuesday Afternoon

MT Newswires Live
·
Aug 27

BUZZ-U.S. STOCKS ON THE MOVE-Trump Media, Gold miners, Cracker Barrel

Reuters
·
Aug 26

BUZZ-Allarity more than doubles on US FDA's 'fast track' tag for ovarian cancer therapy

Reuters
·
Aug 26

Allarity Therapeutics Shares Surge 125% on FDA's Fast Track Tag for Ovarian Cancer Therapy

THOMSON REUTERS
·
Aug 26

Allarity Therapeutics Shares Jump 80% Premarket on FDA's Fast Track Tag for Ovarian Cancer Therapy

THOMSON REUTERS
·
Aug 26

Allarity Therapeutics Says FDA Granted Fast-Track Designation to Stenoparib; Shares Rise Pre-Bell

MT Newswires Live
·
Aug 26

Allarity Therapeutics Granted FDA Fast Track Designation for Stenoparib for the Treatment of Advanced Ovarian Cancer

THOMSON REUTERS
·
Aug 26

Palo Alto Networks, Fabrinet And 3 Stocks To Watch Heading Into Monday

Benzinga
·
Aug 18

Allarity Therapeutics Q2 Operating Income USD -4.133 Million

THOMSON REUTERS
·
Aug 16

Allarity Therapeutics Q2 Net Income USD -2.32 Million

THOMSON REUTERS
·
Aug 16

Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships

GlobeNewswire
·
Aug 16

Allarity Therapeutics Inc. Delays Q2 2025 Financial Report Due to Ongoing Auditor Review

Reuters
·
Aug 15

Allarity Therapeutics Initiated at Buy by Ascendiant Capital

Dow Jones
·
Jul 28

U.S. RESEARCH ROUNDUP-Cognizant, Lam Research, Sarepta Therapeutics

Reuters
·
Jul 28

Allarity Therapeutics Inc : Ascendiant Capital Markets Initiates Coverage With Buy Rating; Price Target $9

THOMSON REUTERS
·
Jul 28

Allarity Therapeutics Signs New Agreement to Expand DRP® Platform Use in Breast Cancer Solutions

Reuters
·
Jul 15

Allarity Therapeutics Announces New Licensing and Laboratory Services Agreement to Expand DRP® Platform Utilization

GlobeNewswire
·
Jul 15